Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices 85537 

include a combination of project-based, 

research and policy experience. 

• Academic degrees, certifications 

and/or training demonstrating green 

building and related sustainability and 

real estate expertise; 

• Knowledge of Federal sustainability 

and energy laws and programs; 

• Proven ability to work effectively 

with a diverse group of professionals in 

a collaborative, multidisciplinary 

environment. 

• Qualifications appropriate to a 

specific statutory category of members 

listed above. 

A nomination package shall include 

the following information for each 

nominee: 

(1) A letter of nomination stating the 

name, title and organization of the 

nominee, nominee’s field(s) of expertise, 

specific qualifications to serve on the 

Committee, and description of interest 

and qualifications; 

(2) A professional resume or CV; and 

(3) Complete contact information 

including name, return address, email 

address, and daytime telephone number 

of the nominee and nominator. 

GSA reserves the right to choose 

Committee members based on 

qualifications, experience, Committee 

balance, statutory requirements and all 

other factors deemed critical to the 

success of the Committee. Candidates 

under consideration may be asked to 

provide specific financial information to 

ensure that the interests and affiliations 

of advisory committee members are 

reviewed for conformance with 

applicable conflict of interest statutes 

and other Federal ethics rules. 

Kinga Porst Hydras, 

Acting Federal Director, Office of Federal 

High-Performance Green Buildings, Office of 

Government-Wide Policy, General Services 

Administration. 

[FR Doc. 2024–24971 Filed 10–25–24; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2024–0085, NIOSH– 

153–F] 

Request for Public Comment on the 

Draft Skin Notation Profiles: Allyl 

Alcohol, Formamide, Formic Acid, 

Phenothiazine, and Picric Acid 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Request for comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) in the Centers for Disease 

Control and Prevention (CDC), an 

Operating Division of the Department of 

Health and Human Services (HHS), 

requests public comment on the draft 

Skin Notation Profiles: Allyl alcohol, 

Formamide, Formic Acid, 

Phenothiazine, and Picric Acid. 

DATES: Electronic or written comments 

must be received by December 27, 2024. 

ADDRESSES: You may submit comments, 

identified by docket number CDC– 

2024–0085 and docket number NIOSH– 

153–F, by either of the following 

methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, OH 45226–1998. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2024–0085; NIOSH–153–F). All 

relevant comments, including any 

personal information provided, will be 

posted without change to https://

www.regulations.gov. Do not submit 

comments by email. CDC does not 

accept comments by email. For access to 

the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Naomi Hudson, DrPH, National Institute 

for Occupational Safety and Health, MS 

C–15, 1090 Tusculum Avenue, 

Cincinnati, OH 45226–1998. Telephone: 

(513) 533–8388. 

SUPPLEMENTARY INFORMATION: NIOSH is 

requesting public comment on draft 

Skin Notation Profile documents for the 

chemicals Allyl alcohol, Formamide, 

Formic Acid, Phenothiazine, and Picric 

Acid. To facilitate the review of these 

documents, NIOSH requests responses 

to the following specific questions for 

each draft Profile document: 

1. Does this document clearly outline 

the systemic health hazards associated 

with exposures of the skin to the 

chemical? If not, what specific 

information is missing from the 

document? 

2. If the SYS or SYS (FATAL) 

notations are assigned, are the rationale 

and logic behind the assignment clear? 

If not assigned, is the logic clear why it 

was not (e.g., insufficient data, no 

identified health hazard)? If not clear, 

what clarification is suggested? 

3. Does this document clearly outline 

the direct (localized) health hazards 

associated with exposures of the skin to 

the chemical? If not, what specific 

information is missing from the 

document? 

4. If the DIR, DIR (IRR), or DIR (COR) 

notations are assigned, are the rationale 

and logic behind the assignment clear? 

If not assigned, is the logic clear why it 

was not (e.g., insufficient data, no 

identified health hazard)? If not clear, 

what clarification is suggested? 

5. Does this document clearly outline 

the immune-mediated responses 

(allergic response) associated with 

exposures of the skin to the chemical? 

If not, what specific information is 

missing from the document? 

6. If the SEN notation is assigned, are 

the rationale and logic behind the 

assignment clear? If not assigned, is the 

logic clear why it was not assigned (e.g., 

insufficient data, no identified health 

hazard)? If not clear, what clarification 

is suggested? 

7. If the ID (SK) or SK were assigned, 

are the rationale and logic outlined 

clearly within the document? If not 

clear, what clarification is suggested? 

8. Are the conclusions supported by 

the data? If not, what changes are 

suggested? 

9. Are the tables clear and 

appropriate? If not, what changes are 

suggested? 

10. Are you aware of any scientific 

data reported in governmental 

publications, databases, peer-reviewed 

journals, or other sources that should be 

considered within this document? 

Please include the full reference citation 

for any additional scientific data to be 

considered. 

11. There have been considerable 

improvements and advancements in 

dermal absorption studies and modeling 

since the publication of NIOSH Current 

Intelligence Bulletin 61: A Strategy for 

Assigning New NIOSH Skin Notations 

[NIOSH 2017]. In response to expert 

external peer reviewers’ comments 

regarding the limitation of the skin to 

inhalation dose (SI) ratio information, 

the SI ratio was removed from the 

individual skin notation profile 

documents. Do you have any 

information to support removing or 

including the SI ratio information in 

these NIOSH documents? 

The draft Skin Notation Profiles were 

developed to provide the scientific 

rationale behind the development of 

skin notation designations for the 

following chemicals: 

• Allyl alcohol (CAS: 107–18–6) 

• Formamide (CAS: 75–12–7) 

• Formic acid (CAS: 64–18–6) 

• Picric acid (CAS: 88–89–1) 

• Phenothiazine (CAS: 92–84–2) 

The Skin Notation Profiles provide a 

detailed summary of the health hazards 


lotter on DSK11XQN23PROD with NOTICES1
85538 Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices 

of chemical exposure to the skin. The 

final publication, which will address 

public comments, will be available on 

the NIOSH website and in the NIOSH 

docket (153–F) and in Regulations.gov 

(CDC–2024–0085). 

Background: In 2009, NIOSH 

published Current Intelligence Bulletin 

(CIB) 61: A Strategy for Assigning New 

NIOSH Skin Notations [NIOSH 2009]. 

The CIB presents a strategic framework 

that is a form of hazard identification 

designed to do the following: 

• Ensure that the assigned skin 

notations reflect the contemporary 

state of scientific knowledge 

• Provide transparency behind the 

assignment process 

• Communicate the hazards of chemical 

exposures of the skin 

• Meet the needs of health 

professionals, employers, and other 

interested parties in protecting 

workers from chemical contact with 

the skin. 

This strategy involves the assignment 

of multiple skin notations for 

distinguishing systemic (SYS), direct 

(DIR), and sensitizing (SEN) effects 

caused by exposure of skin (SK) to 

chemicals. Chemicals that are highly or 

extremely toxic and may be potentially 

lethal or life-threatening following 

exposures of the skin are designated 

with the systemic subnotation (FATAL). 

Potential irritants and corrosive 

chemicals are indicated by the direct 

effects subnotations (IRR) and (COR), 

respectively. The five draft Skin 

Notation Profiles available for review 

were developed following the 

framework in NIOSH CIB 61. 

Reference 

NIOSH [2009]. Current Intelligence 

Bulletin 61: A strategy for assigning 

new NIOSH skin notations. 

Cincinnati, OH: U.S. Department of 

Health and Human Services, 

Centers for Disease Control and 

Prevention, National Institute for 

Occupational Safety and Health, 

DHHS (NIOSH) Publication 2009– 

147, https://www.cdc.gov/niosh/ 

docs/2009-147/. 

Dated: October 23, 2024. 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention, Department of Health and 

Human Services. 

[FR Doc. 2024–24983 Filed 10–25–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10856] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request; 

Withdrawal 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice; withdrawal. 

SUMMARY: On Thursday, September 26, 

2024, the Centers for Medicare & 

Medicaid Services (CMS) published a 

30-day Paperwork Reduction Act of 

1995 notice entitled, ‘‘Agency 

Information Collection Activities: 

Submission for OMB Review; Comment 

Request.’’ The notice invited public 

comment on Document Identifier: CMS– 

10856; Title of Information Collection: 

Medicaid Managed Care and Supporting 

Regulations; and Form Number: CMS– 

10856 (OMB control number 0938– 

1453). Through the publication of this 

document we are withdrawing the 

September 26, 2024, notice in its 

entirety. 

DATES: This withdrawal is applicable on 

October 28, 2024. 

SUPPLEMENTARY INFORMATION: Through 

the publication of this notice we are 

withdrawing FR document 2024–21982 

which published in the Federal Register 

on September 26, 2024 (89 FR 78875). 

Upon further review the associated 

collection of information request was 

not ready for public review and 

comment. The 30-day notice will 

republish at a date to be determined. 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–25019 Filed 10–25–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10912] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

December 27, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number:___, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 


lotter on DSK11XQN23PROD with NOTICES1